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http://dx.doi.org/10.1016/j.asjsur.20Summary Objective: Right ventricular (RV) dysfunction is a significant cause of morbidity
and mortality after surgical correction of tetralogy of Fallot (TOF). Transatrial/transpulmonary
repair avoids a ventriculotomy (in contrast to the transventricular approach) in order to pre-
serve the structure and function of the right ventricle. We performed a pilot prospective ran-
domized controlled trial in infants with TOF undergoing primary repair.
Methods: A pilot prospective controlled clinical trial was conducted in infantswith TOF undergoing
primary repair between January 2008 and December 2009. One hundred and six patients were re-
cruited in the trial and divided into a transatrialetranspulmonary approach group (Group A;
nZ 53) and a transventricular approach group (Group B; nZ 53), depending on the different sur-
gical techniques used.
Results: Preoperative patient characteristics and procedure-related variables were similar. There
were no deaths in Group A, while two patients died in Group B. There were significant differ-
ences in cardiopulmonary bypass time (95.02  23.8 vs. 85.23  22.63 minutes, p Z 0.032),
cross-clamp time (69.4  10.36 vs. 61.17  9.38 minutes, p Z 0.035), inotropic support
(1.63  0.97 vs. 2.1  1.09 days, p Z 0.02), intubation time (26.62  12.48 vs. 33.02  17.55
hours, p Z 0.033), duration of stay in the intensive care unit (ICU) (2.25  1.28 vs.
2.85  1.46 days, pZ 0.026), and the incidence of arrhythmia [3 patients (5.7%) vs. 10 patients
(18.9%), pZ 0.038]. No significant differences in right/left ventricular pressure ratio and hospital
stay were observed.of Cardiovascular Surgery, Xinqiao Hospital, Third Military Medical University, 183 Xinqiao Street,
m (Y. Xiao).
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138 G. Sun et al.Conclusion: Transatrial/transpulmonary repair of TOF is associated with excellent surgical results
and immediately follow-up.
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reserved.1. Introduction
Tetralogy of Fallot (TOF) is the most common cyanotic
congenital heart disease1 characterized by large ventricular
defect (VSD), right ventricular hypertrophy, right ventricular
outflow tract (RVOT) obstruction, and an over-riding aorta.
Since the first successful repair of TOF by Lillehei and asso-
ciates in 1954 in a 10-year-old boy,2 this most common
cyanotic heart disease has been studied extensively; how-
ever, controversies still exist regarding whether an early
primary repair or a two-stage approach is the technique of
choice.3 An early primary repair is preferred for several rea-
sons, including reduction of Right ventricular (RV) pressure
overload and elimination of hypoxemia, cyanosis, and sec-
ondary organ damage. The optimal age and surgical approach
of TOF have been debated for several decades. Currently,
most centers favor primary elective repair in infancy.4e7
Traditionally, TOF was repaired through an RV incision
providing an excellent exposure for closure of the VSD and
relief of RVOT obstruction. However, RV function is
impaired after ventriculotomy owing to a reduction in the
regional wall motion around the incision,8 which may in-
crease the incidence of ventricular arrythmias and sudden
death. The right atrial approach (combined with a trans-
pulmonary approach) to repair of TOF was reported by
Hudspeth and coworkers in 1963.9 Subsequently, it has
been shown that TOF can be repaired reliably through a
transatrial/transpulmonary approach,10e13 which avoids
the impairment of RV function caused by ventriculotomy.
However, no perspective data are available to the surgeon
to compare the two approaches and adopt the optimal
one.
The principal aim of our study randomized controlled
trial was to compare between the transatrial/trans-
pulmonary and transventricular approaches for the primary
repair of TOF in infancy by evaluating their advantages and
disadvantages and find the optimal approach.
2. Methods
2.1. Patient selection
This study was approved by the Institutional Review Board of
Third Military Medical University, and was in compliance
with the Health Insurance Portability and Accountability Act
Regulations and the Declaration of Helsinki. The Institu-
tional Review Board waived the need for individual patient
consent. We used the consolidated standards of reporting
trials checklist for design and conduct of this study.
In total, 106 patients were recruited in this study be-
tween January 2008 and December 2009. An informed pa-
tient consent was obtained before operation. For this study,patients with TOF but without important complicated fea-
tures were selected. Such patients were considered to be
those with classic TOF who underwent repair without using a
valved extracardiac conduit or an orthotopically inserted
pulmonary valve substitute. All patients were diagnosed by
echocardiography and cardiac computed tomography. The
McGoon ratio and left ventricular volume index of diastolic
end (LVEDVI) were calculated. The patients with a McGoon
ratio of <1.2 and an LVEDVI of <30 mL/m2 were excluded.
Patients undergoing a two-stage operation and the abnormal
coronary artery course (double-left anterior descending
branches, preventing a transventricular approach to repair
TOF) were also excluded.
2.2. Randomization
Randomization was undertaken with sequential closed en-
velopes containing the treatment strategies assigned to
each patient. In each case, the surgeon opened the enve-
lope on the day of surgery to assign the treatment strategy
to each patient.
2.3. Surgical technique
All complete repairs were performed after standard median
sternotomy using a cardiopulmonary bypass with moderate
systemic hypothermia (25e28C). The patent ductus arte-
riosus was repaired before cross-clamping the ascending
aorta to prevent lung perfusion. Antegrade cold crystalloid
and cold blood cardioplegia were used for myocardial pro-
tection. The transatrial/transpulmonary surgical approach
was adopted in Group A and transventricular surgical
approach in Group B.
In Group A, visualization of the VSD was usually adequate
through the tricuspid valve and was even easier after divi-
sion and resection of the obstructing muscle bundles. An
autologous pericardial patch (washed in 0.6% glutaralde-
hyde for 10 minutes) was cut to the appropriate size, usually
equal to the diameter of the mid ascending aorta. It was
then sutured to the right side of the septum with a contin-
uous suture technique, with 6-0 Prolene ACC. Suturing was
usually started on the anterior limb of the septal band, as
close as possible to the aortic valve, and continued inferiorly
to the angle between the anterior and posterior limbs of the
septal band, past the medial papillary muscle and under any
chordae tendinae from the septal leaflet, until the poster-
oinferior rim of the defect was reached. At this point, su-
turing must be done approximately 5 mm away from the
crest of the VSD itself and only on the RV side, to avoid injury
to the atrioventricular node or bundle of His. This initial arm
of the suture was then brought to the right atrium passing
the needle through the septal leaflet annulus of the
tricuspid valve, away from the coronary sinus orifice and the
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over the infundibular septum and the aortic valve annulus,
without injuring the aortic valve leaflets. The root of the
aorta was pressed when it difficult to expose the aortic valve
annulus. The sutures were kept close to the aortic valve
annulus to avoid residual interventricular shunts. The nee-
dle was then brought to the atrium through the anterior
leaflet of the tricuspid valve at its junction with the ven-
triculoinfundibular fold. Finally, the patch was sutured
under the septal leaflet of the tricuspid valve, over the
penetrating bundle, down to the needle of the first arm of
the suture. Pericardial pledgets might be used to reinforce
the suturing at the septal leaflet.
In Group B, a longitudinal incision was made in the right
ventricle, a few millimeters away from the pulmonary
valve. The obstructing muscles in the RVOT were excised
until the VSD could be detected clearly. The VSD was closed
with an autologous pericardial patch. After pulling the
patch down, the sutures were continued in a clockwise
fashion, taking care to keep it on the right side of the
septum. In the region of the bundle of His, it was safer to
place the sutures in the base of the tricuspid valve leaflet.
Particularly in case of a very thin tissue, extra pledgeted
sutures could be used. The other end of the continuous
suture was used to run round in an anticlockwise manner
and a knot was tied at the top. If the annulus was not
enough, the incision was carried upward through the pul-
monary valve to the bifurcation of the main pulmonary
artery. In case of a proximal narrowing in one of the indi-
vidual pulmonary arteries, the incision should be continued
across the stenotic part. When making the incision through
the pulmonary valvular annulus, it is best to try to take the
incision between cusps so as to preserve the cusps. To
assess the adequacy of the RVOT, Hegar’s dilators were
introduced through RVOT to assess adequacy based on
normalized sizes according to for body surface area.14 In
addition, peak RV/LV pressure ratio was measured by direct
RV puncture to rule out any significant residual outflow
tract obstruction. For a postrepair ratio of <0.7, the RVOT
appeared to be reconstructed adequately. Pulmonary
annulus was enlarged by a glutaraldehyde-treated autolo-
gous pericardial patch when necessary. TransesophagealTable 1 Clinical characteristics of patients.
Variables Group A (n Z 53)
Mean age (D  SD) 11.53  5.58
Sex ratio (M/F) 26/27
Weight (kg) 7.61  2.27
Body surface area 0.52  0.14
Hematocrit (%) 47.28  8.16
Cyanotic spell history (%) 8 (15.1%)
Arrhythmias 4 (7.5%)
RV-PA mean gradient (mmHg) 84.6  11.25
NYHA class III-IV 6 (11.3%)
McGoon ratio 1.46  0.23
LVEDVI (mL/m2) 38.37  8.66
Types of arrhythmia identified were atrial fibrillation in three and no
Group A Z transatrialetranspulmonary approach; Group B Z transv
diastolic end; NYHA Z New York Heart Association; RV Z right ventrechocardiography was used to evaluate the surgical result
immediately.
Associated cardiac anomalies, such as patent ductus
arteriosus, or patent foramen ovale were treated simulta-
neously. The major aortopulmonary collateral arteries were
evaluated by the doctor and coil embolization was
performed.
2.4. Data management and statistical analysis
The data were managed and analyzed using SPSS13.0. All
continuous variables were expressed as mean  standard
deviation (M  SD). Continuous variables were compared by
standard t tests. Categorized variables were analyzed with
chi-square tests. All statistical tests were two tailed. A p
value of <0.05 was considered statistically significant.
3. Results
3.1. Demographic and clinical characteristics
Patient characteristics and procedure-related variables
were similar. Fifty-three patients (26 boys and 27 girls,
aged 11.53  5.58 months) were assigned to Group A
(transatrialetranspulmonary approach group) and 53 pa-
tients (28 boys and 25 girls, aged 10.43  4.7 months) to
Group B (transventricular approach group). There was no
significant difference in the McGoon ratio and LVEDVI be-
tween the groups. Both groups were comparable for patient
characteristics and procedure-related parameters (Tables 1
and 2).
3.2. Perioperative profile
Two patients died in Group B compared with no death in
Group A (Table 3). Overall, two patients died in the hos-
pital: one patient for serious low cardiac output syndrome
and multiple organ failure, and the other for malignant
arrhythmia of ventricular fibrillation and ventricular
flutter.Group B (n Z 53) t/c2 p
10.43  4.7 1.09 0.278
28/25 0.151 0.698
7.06  2.05 1.301 0.196
0.49  0.13 0.986 0.327
48.73  8.61 0.889 0.376
11 (20.8%) 0.577 0.613
3 (5.7%) 0.153 >0.99
81.64  12.63 0.382 0.703
10 (18.9%) 1.18 0.416
1.49  0.26 0.794 0.429
41.36  11.47 1.512 0.134
nsustained ventricular tachycardia in four.
entricular approach; LVEDVI Z left ventricular volume index of
icular; SD Z standard deviation.
Table 2 Associated congenital cardiac abnormalities.
Variables Group A (n Z 53) Group B (n Z 53) t/c2 p
Patent foramen ovale (%) 17 (32.1%) 7 (13.2%) 5.386 0.02
Patent ductus arteriosus at time of complete repair (%) 7 (13.2%) 4 (7.5%) 0.913 0.339
Atrial septal defect (%) 11 (20.8%) 9 (17%) 0.247 0.62
Right aortic arch (%) 3 (5.7%) 0 3.087 0.079
MAPCAs (%) 8 (15.1%) 6 (11.3%) 0.329 0.566
Left superior vena cava (%) 2 (3.8%) 8 (15.1%) 3.975 0.046
MAPCAs Z major aortopulmonary collateral arteries.
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bypass time (95.02  23.8 vs. 85.23  22.63 minutes,
pZ 0.032), cross-clamp time (69.4  10.36 vs. 61.17  9.38
minutes, p Z 0.035), inotropic support (1.63  0.97 vs.
2.1  1.09 days, pZ 0.02), intubation time (26.62  12.48
vs. 33.02  17.55 hours, pZ 0.033), duration of stay in the
intensive care unit (ICU) (2.25  1.28 vs. 2.85  1.46 days,
p Z 0.026), and the incidence of arrhythmia [3 patients
(5.7%) vs. 10 patients (18.9%), p Z 0.038] between the
two groups. No difference was observed in RV/LV pressure
ratio (0.45  0.13 vs. 0.41  0.1, p Z 0.091), hospital
stay (10.8  2.03 vs. 10.6  2.37 days, p Z 0.642),
reoperation [3 patients (5.7%) vs. 0 patients, p Z 0.079],
and newly diagnosed renal insufficiency (1, 1.9% vs. 2, 3.8%,
p Z 0.558) between two groups (Table 3). In Group A,
two infants were reoperated for bleeding and one for a
twist of the left pulmonary artery, using a transannular
patch (TAP).
Echocardiography did not reveal residual VSD in any
patient before discharge. The RVOT pressure gradient was
low without significant hemodynamic effects. Most pa-
tients in both groups had mild pulmonary insufficiency.
Only 5.7% in Group A and 11.8% in Group B had moder-
ateesevere pulmonary insufficiency. Mildemoderate
impairment of RV function occurred only in a few patients
(3.8% in Group A and 7.84% in Group B). Tricuspid valveTable 3 Perioperative data.
Variables Group A
CPB time (min) 95.02  2
Cross-clamp time (min) 69.4  20
RV/LV pressure ratio 0.45  0.
Inotropic support (d) 1.63  0.
Intubation time (h) 26.62  1
ICU stay (d) 2.25  1.
Hospital stay (d) 10.8  2.
Complications
Reoperation 3 (5.7%)
Presence of low cardiac output (no. patients) 1 (1.9%)
Renal insufficiency (newly diagnosed) 1 (1.9%)
Arrhythmiasa 3 (5.7%)
Mortality 0
CPB Z cardiopulmonary bypass; Group A Z transatrialetransp
ICU Z intensive care unit; LV Z left ventricular; RV Z right ventricu
a Types of arrhythmia identified were atrial fibrillation, supraventrifunction was well preserved and most patients had mild
Tricuspid valve insufficiency (TI). Overall, RV and LV
functions were well preserved. Predischarge echocardi-
ography data are summarized in Table 4.3.3. Follow-up data
The mean follow-up period was 39.6  5.59 months. No
significant residual lesion has been detected and no reop-
eration has been necessary. One died from severe lung
infection with ventricular arrhythmia during late follow-up.
Detailed echocardiographic late follow-up data are sum-
marized in Table 5. Specifically, during this follow-up
period, the RVOT remained free of significant obstruction,
and pulmonary insufficiency or tricuspid valve insufficiency
did not progress. Thus, mean RVOT gradient remained low
and no patient has developed significant RVOT obstruction.
More patients who underwent transventricular repaired
developed arrhythmia, especially nonsustained ventricular
tachycardia, than those who underwent transatrial/trans-
pulmonary surgery (1.96% vs. 14%, p Z 0.025). RV function
remained stable during this follow-up period in patients in
whom the transatrial/transpulmonary approach was used,
while it was impaired later in those in whom the trans-
ventricular approach was used (0 vs. 8%, p Z 0.039).(n Z 53) Group B (n Z 53) t/c2 p
3.8 85.23  22.63 2.17 0.032
.36 61.17  19.38 2.13 0.035
13 0.41  0.1 1.71 0.091
97 2.1  1.09 2.36 0.02
2.48 33.02  17.55 2.16 0.033
28 2.85  1.46 2.27 0.026
03 10.6  2.37 0.466 0.642
0 3.087 0.079
5 (9.4%) 2.827 0.093
2 (3.8%) 0.343 0.558
10 (18.9%) 4.3 0.038
2 (3.8%) 2.04 0.153
ulmonary approach; Group B Z transventricular approach;
lar.
cular tachycardia, and nonsustained ventricular tachycardia.
Table 4 Echocardiographic data on hospital discharge.
Variables Group A (n Z 53) Group B (n Z 51) t/c2 p
Right ventricular outflow tract pressure gradient 14.46  6.15 13.47  6.9 0.768 0.444
Pulmonary insufficiencya 3 (5.7%) 6 (11.8%) 1.23 0.268
Tricuspid regurgitationa 5 (9.4%) 4 (7.84%) 0.083 0.773
Right ventricular functionb 2 (3.8%) 4 (7.84%) 0.792 0.374
a Moderate or severe insufficiency.
b Mildemoderate impairment.
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TOF has been known to exist for more than 100 years and
the typical cardiac abnormalities have been known to sur-
geons. The operative correction of TOF has been performed
for more than 40 years.15 The varied features of this defect
and sequelae after repair have been understood better in
the past two decades. The timing of surgical correction of
TOF is controversial. The predominant trend in the timing
of surgical procedure has been toward an earlier inter-
vention with elective repair within the first 4e6 months of
life,3 although others have advocated earlier repairs in
symptomatic neonates.16,17 According to the results of
many studies,18e21 the surgical procedure can be per-
formed with relatively low mortality (0e7%). In our center,
the correction of TOF was performed in infants usually
older than 6 months.
Generally, it is accepted that early correction of TOF
minimizes secondary damages to the heart, lungs, and
nervous system and that functional results after elective
primary repair early in infancy are superior to either two-
stage repair or repair later in life. However, primary repair
during infancy may need more frequent use of a TAP, but
the association between the use of a TAP and the long-term
outcome is uncertain. The myriad reports showed that TAP
could lead to long-term pulmonary valve insufficiency (PI),
although this remains a controversial issue. Several studies
have demonstrated good long-term outcomes after repair
of TOF with a TAP. Bacha and colleagues22 reported that the
functional status, as measured by the New York Heart As-
sociation class, was similar to TAP and valve-sparing. Kir-
klin’s group23 found that the risk of reoperation for PI at 20
years was 7%; they ascribed this low rate of reoperation,
despite a significant incidence of PI, to the adaptiveTable 5 Late follow-up clinical and echocardiographic data.
Variables Group A
NYHA class IeII 51 (96.2%
Arrhythmiasa 1 (1.89%
Right ventricular outflow tract pressure gradient 12.16 
Pulmonary insufficiencyb 3 (5.66%
Tricuspid regurgitationb 5 (9.43%
Right ventricular functionc 0
NYHA Z New York Heart Association.
a Atrial fibrillation, supraventricular tachycardia, and nonsustained
b Moderate or severe insufficiency.
c Mildemoderate impairment.properties of the right ventricle. These findings are con-
tradicted by other studies showing the deleterious effects
of pulmonary insufficiency on the right ventricle. Cardiac
magnetic resonance cine examinations of TOF patients late
after repair have demonstrated that PI is closely associated
with TAP and results in significant RV dysfunction, even in
asymptomatic patients.24,25 Gatzoulis and associates26
showed that PI and TAP are associated with the develop-
ment of ventricular tachycardia and sudden death late
after TOF repair. The group at the Great Ormond Street
found that a total of 124 patients with TAPs were highly
associated with PI and PI was associated with RV and LV
dysfunctions.27 The late effects of TAP and PI on both RV
and patient functional status are further documented by
the growing number of reports on the ventricular
improvement and symptomatic relief achieved with pros-
thetic pulmonary valve insertion late after repair.28e30
In our study, slicing technique of the RVOT was a crucial
step in the transatrialetranspulmonary repair of TOF, which
could relieve the obstructive RVOT.31 In addition, we made
great efforts to avoid a TAP in order to preserve the annulus
and pulmonary valve, which may improve the postoperative
RV function and reduce long-term complications including
arrhythmias and PI. In those cases, an infundibular patch
was required; we think that two patches above and below
the annulus are preferable to a single patch crossing the
annulus. This is consistent with the recommendation of the
Northwestern University group: avoidance of a TAP with
preservation of the annulus of the pulmonary valve.30
Minimal incision in the right ventricle was another way to
preserve RV function.
RV diastolic dysfunction often occurs in patients
following repair of TOF. The postoperative course in those
patients is characterized by low cardiac output, longer(n Z 53) Group B (n Z 50) t/c2 p
) 46 (92%) 1.516 0.22
) 7 (14%) 5.13 0.024
5.56 11.6  6.84 0.648 0.56
) 9 (20%) 3.659 0.056
) 4 (8%) 0.066 0.797
4 (8%) 4.411 0.036
ventricular tachycardia.
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longer chest drainage time. Therefore, assessment of RV
diastolic function is important in patients undergoing
correction of TOF, particularly in those in whom a trans-
ventricular approach was used. Index of myocardial per-
formance (IMP) is a new parameter, which has been
validated as the measure of both systolic and diastolic
functions of the right ventricle. Sachdevand colleagues
reported32 the lower the IMP, the more the possibility for
the surgical approach to have complications during the
postoperative course with a longer duration of inotropic
support, ventilation time and ICU stay, higher central filling
pressures, prolonged chest tube drainage, and a higher
dose of diuretics. However, as time goes by, RV dysfunction
and pulmonary valve insufficiency slowly develop in almost
all patients to some degree.33 Exercise capacity decreases
in patients with RV dilation, but most patients remain
asymptomatic. Pulmonary valve replacement (PVR) may be
a frequent consideration for patients with fatigue and ex-
ercise intolerance. PVR unexplained by factors other than
RV dilatation and dysfunction would be a strong indication
for valvular replacement. It is associated with improve-
ments in exercise performance, as well as in RV size and
function.30
Transmural myocardial scarring of the right ventricle is
an important factor in the development of malignant ven-
tricular arrhythmias. The QRS prolongation (>180 ms) is the
most sensitive predictor of development of malignant
ventricular arrhythmias.33 Transatrialepulmonary correc-
tion of TOF may prevent the incision in RV and reduce the
incidence of ventricular arrhythmias. The smaller the
incision, the more the possibility of avoiding malignant
ventricular arrhythmias if ventriculotomy is necessary. The
relation between RV dilatation and ventricular arrhythmias
(and sudden death) is controversial.
A limitation of the present study is its relatively short
period of follow-up, which should be long enough to obtain
more detailed information on the RV function by magnetic
resonance imaging or IMP.
In conclusion, we assume that TOF can be corrected
safely in infancy. This can also be accomplished safely in
all patients and should be attempted despite symptoms,
minimizing the injury on the RV muscular structures, and
preserving the structure and function of the right
ventricle for a better long-term outcome of this growing
population.References
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